ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Chatham, New Jersey Wednesday, November 6, 2024, 18:00 Hrs [IST] ...

Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the SIGA ...

The Company's most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus. Olvi-Vec currently is being evaluated in ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

The World Health Organization (WHO) has declared a global health emergency over a new strain of mpox that is spreading ...

A NEW strain of the mpox virus has been detected in the UK, and now an expert has warned not to confuse the symptoms with ...

The Department of Microbiology and Immunology is one of 25 departments within the RSOM. It is dedicated to advancing the ...

myvac is a viral vector (MVA—Modified Vaccinia Ankara) based, individualized immunotherapy platform that has been developed by Transgene to target solid tumors. myvac-derived products are designed to ...

Protein vaccines are composed of purified or recombinant proteinaceous antigens from a pathogen, such as a bacterium or virus. When administered, a protective immune response is elicited against ...